BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2011
View Archived Issues
Novel PLK4 inhibitors demonstrate antiproliferative activity in models of breast cancer
Read More
Arena Pharma describes new potent and selective lysophospholipid S1P1 receptor agonists
Read More
Frizzled SMO receptor inhibitor LY-2940680 exhibits antitumor effects in vivo
Read More
Nile Pax paclitaxel-eluting stent successfully treats coronary bifurcation lesions
Read More
Danoprevir/ritonavir shows anti-HCV efficacy in combination with P/R in P/R null reponders
Read More
Myrcludex B blocks spread of hepatitis B virus in infected humanized mice
Read More
Livatag improves survival of patients with advanced hepatocellular carcinoma
Read More
La Jolla Pharma focuses on regenerative medicine following acquisition of GliaMed's RILs
Read More
Bayer and Regeneron begin phase III VEGF Trap-Eye trial in diabetes-related macular edema
Read More
Acadia Pharma and Allergan extend eye care collaboration
Read More
New macrocyclic JAK3 inhibitors patented by Roche
Read More
Boehringer Ingelheim patents novel inhibitors of HCV NS5B
Read More
Merck & Co. prepares novel glucocorticoid receptor ligands
Read More
Sunovion reports new histamine H3 receptor antagonists/inverse agonists
Read More
U.S. researchers patent novel nucleoside phosphonates
Read More
Alnylam extends RNAi collaboration with AlCana and University of British Columbia
Read More
Novartis completes merger with Alcon, adding eye care as growth platform
Read More
Champions Oncology exercises option to license Irinophore C
Read More
Allergy Therapeutics submits MAA in Switzerland for Grass MATA MPL
Read More
FDA accepts Antares Pharma's Anturol NDA for filing
Read More
Nuron Biotech acquires Hibtiter conjugate vaccine assets from Wyeth
Read More
Sanofi-aventis completes acquisition of Genzyme
Read More
Novartis discontinues phase III Tasigna trial in gastrointestinal stromal tumors
Read More
Takeda and Heptares to research G protein-coupled receptor in CNS disorders
Read More
StemCells discontinues phase Ib HuCNS-SC trial in neuronal ceroid lipofuscinosis
Read More
FDA clears Cepheid Xpert C. difficile/Epi assay for CDI
Read More